Caribou Bioscience Q4 2023 Financial Results Analysis
Monday, 11 March 2024, 20:52
Caribou Bioscience Q4 2023 Earnings Review
Caribou Bioscience reported their financial results for Q4 2023. The GAAP EPS was in line with expectations, but the revenue missed the forecast. This analysis delves into the performance of Caribou Bioscience for the quarter, highlighting the key financial metrics.
Key Points:
- GAAP EPS: -$0.39 (in-line)
- Revenue: $3.56M (misses by $1.05M)
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.